EMCDDA. Most recent data from the European Syringe Collection and Analysis Project Enterprise (ESCAPE): data explorer, analysis and key findings
EMCDDA. Most recent data from the European Syringe Collection and Analysis Project Enterprise (ESCAPE): data explorer, analysis and key findings
Background and introduction
While evidence from drug treatment centres suggests that injecting drug use is declining among heroin clients in the European Union, the risk of overdose death and infectious diseases associated with this mode of administration remains high. The injection of stimulants — including cocaine and synthetic cathinones — has been linked to increased risk of HIV and hepatitis B and C virus (HBV/HCV) transmission, through increased frequency of use and sharing of injecting paraphernalia. Knowledge of what substances are being injected is important to guide prevention strategies and plan the provision of harm reduction interventions. (EMCDDA, Lissabon, 11.09.2023)
https://www.emcdda.europa.eu/publications/data-factsheet/syringe-residues-analysis-data-escape-project_en